Pfizer (PFE) Advances Development of Danuglipron
Go back to Pfizer (PFE) Advances Development of Danuglipron| Pfizer Inc. (NYSE: PFE) | Delayed: 25.00 -0.21 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.21 | 52 Week High | $37.39 | |||
| Open | $25.22 | 52 Week Low | $28.25 | |||
| Day High | $25.31 | P/E | 15.15 | |||
| Day Low | $24.96 | EPS | $1.65 | |||
| Volume | 26,933,301 | |||||

